Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Department of Gynecology and Obstetrics, Magna Graecia University of Catanzaro, Catanzaro, Italy. stefanopalomba@tin.it
Metformin, an insulin sensitizer widely used for the treatment of patients with type-2 diabetes mellitus (DM), was recently introduced in the clinical practice to treat women with polycystic ovary syndrome (PCOS). The aim of the current review was to evaluate the current role of metformin in the treatment of the PCOS-related disorders. The Authors analyze here the administration of metformin for treating the ovarian dysfunction due to PCOS, and show the evidences available in literature regarding its alternative uses.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on